The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
PTEN coordinates G1 arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model
Open accessAbstract
The tumour suppressor gene PTEN/MMAC1/TEP1 encodes a dual-specificity phosphatase that recognizes phosphatidylinositol-3,4,5-triphosphate and protein substrates. We have shown previously that over-expression of PTEN in a tetracycline-controlled inducible system blocks cell cycle progression and induces apoptosis in MCF-7 breast cancer cells. Here, we demonstrate that over-expression of wild-type PTEN leads to the suppression of cell growth through the blockade of cell cycle progression, an increase in the abundance of p27, a decrease in the protein levels of cyclin D1 and the inhibition of Akt phosphorylation. In contrast, expression of the phosphatase-dead mutant, C124S, promotes cell growth and has the opposite effect on the abundance of p27, cyclin D1 levels and the phosphorylation of Akt. The G129E mutant, which does not have lipid phosphatase activity but retains protein phosphatase activity, behaves like C124S except that the former causes decreases in cyclin D1 levels similar to wild-type PTEN. Therefore, PTEN exerts its growth suppression through lipid phosphatase-dependent and independent activities and most likely, via the coordinate effect of both protein phosphatase and lipid phosphatase activities. Addition of either estrogen or insulin abrogates PTEN-mediated up-regulation of p27 and partially blocks PTEN-mediated growth suppression, whereas the combination of estrogen and insulin eliminates the alterations of p27 and cyclin D1 and completely blocks PTEN-mediated growth suppression. Our findings demonstrate that PTEN blocks cell cycle progression differentially through down-regulating the positive cell cycle regulator, cyclin D1, by its protein phosphatase activity, and up-regulating the negative cell cycle regulator, p27, by its lipid phosphatase activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
Mechanisms and consequences of activation of protein kinase B/Akt
Downward, J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80149-x · Cited by 1,303
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
Tamura, M., Gu, J., Matsumoto, K., Aota, S.-I., Parsons, R., & Yamada, K. M. (1998) · Science · doi:10.1126/science.280.5369.1614 · Cited by 1,215
The lipid phosphatase activity of PTEN is critical for its tumor supressor function
Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., & Tonks, N. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13513 · Cited by 1,168
Crystal Structure of the PTEN Tumor Suppressor
Lee, J.-O., Yang, H., Georgescu, M.-M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., & Pavletich, N. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81663-3 · Cited by 1,014
Li, D., & Sun, H. (1997) · PubMed · Cited by 866
Germline mutations in PTEN are present in Bannayan-Zonana syndrome
Marsh, D. J., Dahia, P. L. M., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J., & Eng, C. (1997) · Nature Genetics · doi:10.1038/ng0897-333 · Cited by 655
Marsh, D. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.507 · Cited by 653
Marsh, D. J., Kum, J. B., Lunetta, K. L., Bennett, M. J., Gorlin, R. J., Ahmed, S. F., Bodurtha, J., Crowe, C., Curtis, M. A., Dasouki, M., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1461 · Cited by 612
Self-citationImpaired Fas Response and Autoimmunity in Pten +/− Mice
Cristofano, A. D., Kotsi, P., Peng, Y. F., Cordon-Cardo, C., Elkon, K. B., & Pandolfi, P. P. (1999) · Science · doi:10.1126/science.285.5436.2122 · Cited by 521
Li, D.-M., & Sun, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15406 · Cited by 489
Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
Furnari, F. B., Lin, H., Huang, H.-J. S., & Cavenee, W. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12479 · Cited by 434
Furnari, F. B., Huang, H., & Cavenee, W. K. (1998) · PubMed · Cited by 395
Perren, A., Weng, L.-P., Boag, A. H., Ziebold, U., Thakore, K., Dahia, P. L. M., Komminoth, P., Lees, J. A., Mulligan, L. M., Mutter, G. L., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65227-3 · Cited by 378
Self-citationp70s6k function is essential for G1 progression
Lane, H. A., Fernandez, A., Lamb, N. J. C., & Thomas, G. (1993) · Nature · doi:10.1038/363170a0 · Cited by 345
Bifurcation of Lipid and Protein Kinase Signals of PI3Kγ to the Protein Kinases PKB and MAPK
Bondeva, T., Pirola, L., Bulgarelli-Leva, G., Rubio, I., Wetzker, R., & Wymann, M. P. (1998) · Science · doi:10.1126/science.282.5387.293 · Cited by 314
Li, J., Simpson, L., Takahashi, M., Miliaresis, C., Myers, M. P., Tonks, N. K., & Parsons, R. E. (1998) · PubMed · Cited by 306
Weng, L., Smith, W. M., Dahia, P. L. M., Ziebold, U., Gil, E., Lees, J. A., & Eng, C. (1999) · PubMed · Cited by 285
Self-citationDavies, M. A., Lu, Y., Sano, T., Fang, X., Tang, P., LaPushin, R., Koul, D., Bookstein, R., Stokoe, D., Yung, W. K. A., et al. (1998) · PubMed · Cited by 270
Dufourny, B., Alblas, J., van Teeffelen, H. A. A. M., van Schaik, F. M. A., van der Burg, B., Steenbergh, P. H., & Sussenbach, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.31163 · Cited by 257
Zhou, X.-P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.5.765 · Cited by 215
Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
Cheney, I. W., Johnson, D. E., Vaillancourt, M. T., Avanzini, J. B., Morimoto, A. M., Demers, G. W., Wills, K. N., Shabram, P. W., Bolen, J. B., Tavtigian, S. V., et al. (1998) · PubMed · Cited by 188
Takuwa, N., Fukui, Y., & Takuwa, Y. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1346 · Cited by 182
Genetics of Cowden syndrome: through the looking glass of oncology.
Eng, C. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.3.701 · Cited by 157
Cheney, I. W., Neuteboom, S., Vaillancourt, M. T., Ramachandra, M., & Bookstein, R. (1999) · PubMed · Cited by 133
PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein
Paramio, J. M., Navarro, M., Segrelles, C., Gómez‐Casero, E., & Jorcano, J. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203151 · Cited by 129
Phosphoinositide 3-kinase and the regulation of cell growth
Carpenter, C. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00018-2 · Cited by 118
PTEN: Sometimes Taking It Off Can Be Better than Putting It On
Myers, M. P., & Tonks, N. K. (1997) · The American Journal of Human Genetics · doi:10.1086/301659 · Cited by 94
Kanda, S., Hodgkin, M. N., Woodfield, R. J., Wakelam, M. J. O., Thomas, G., & Claesson, L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.23347 · Cited by 93
PTEN and inherited hamartoma-cancer syndromes
Eng, C., & Peacocke, M. (1998) · Nature Genetics · doi:10.1038/897 · Cited by 83
Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene.
Minaguchi, T., Mori, T., Kanamori, Y., Matsushima, M., Yoshikawa, H., Taketani, Y., & Nakamura, Y. (1999) · PubMed · Cited by 64
Hlobílková, A., Guldberg, P., Thullberg, M., Zeuthen, J., Lukas, J., & Bártek, J. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4867 · Cited by 64
Cited by
PTEN loss in the continuum of common cancers, rare syndromes and mouse models
Hollander, M. C., Blumenthal, G. M., & Dennis, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3037 · Cited by 794
PTEN: One Gene, Many Syndromes
Eng, C. (2003) · Human Mutation · doi:10.1002/humu.10257 · Cited by 787
Clinical implications of PTEN loss in prostate cancer
Jamaspishvili, T., Berman, D. M., Ross, A. E., Scher, H. I., De Marzo, A. M., Squire, J. A., & Lotan, T. L. (2018) · Nature Reviews Urology · doi:10.1038/nrurol.2018.9 · Cited by 651
PTEN signaling pathways in melanoma
Wu, H., Goel, V., & Haluska, F. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206451 · Cited by 480
Protean PTEN: Form and Function
Waite, K. A., & Eng, C. (2002) · The American Journal of Human Genetics · doi:10.1086/340026 · Cited by 457
“Several groups have shown that PTEN coordinates G1 arrest through up-regulation of p27 and concomitant down-regulation of cyclin D1 (Cheney et al. 1999; Bruni et al. 2000; Medema et al. 2000; Persad et al. 2001; Weng et al. 2001a).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Weng, L.-P.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-03-01
- Volume
- 10
- Issue
- 6
- Pages
- 599-604
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2111062014
- Cited by
- 264
- References
- 36
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.